berotek has been researched along with Hypercapnia in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshiike, Y | 2 |
| Suzuki, S | 2 |
| Watanuki, Y | 2 |
| Okubo, T | 2 |
2 trials available for berotek and Hypercapnia
| Article | Year |
|---|---|
Effects of fenoterol on ventilatory responses to hypoxia and hypercapnia in normal subjects.
Topics: Adult; Double-Blind Method; Fenoterol; Humans; Hypercapnia; Hypoxia; Male; Middle Aged; Random Alloc | 1995 |
Effects of fenoterol on ventilatory response to hypercapnia and hypoxia in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Chemoreceptor Cells; Cross-Over Studies; Double-B | 1997 |